These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11432692)

  • 21. A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria.
    Steinberg S; Annable L; Young SN; Liyanage N
    Adv Exp Med Biol; 1999; 467():85-8. PubMed ID: 10721042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study.
    Sumiyoshi T; Park S; Jayathilake K; Roy A; Ertugrul A; Meltzer HY
    Schizophr Res; 2007 Sep; 95(1-3):158-68. PubMed ID: 17628435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Responders to antidepressant drug treatment: a study comparing nefazodone, imipramine, and placebo in patients with major depression.
    Cohn CK; Robinson DS; Roberts DL; Schwiderski UE; O'Brien K; Ieni JR
    J Clin Psychiatry; 1996; 57 Suppl 2():15-8. PubMed ID: 8626358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment of premenstrual dysphoria.
    Eriksson E; Andersch B; Ho HP; Landén M; Sundblad C
    J Clin Psychiatry; 2002; 63 Suppl 7():16-23. PubMed ID: 11995774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nefazodone in the treatment of generalized social phobia: a randomized, placebo-controlled trial.
    Van Ameringen M; Mancini C; Oakman J; Walker J; Kjernisted K; Chokka P; Johnston D; Bennett M; Patterson B
    J Clin Psychiatry; 2007 Feb; 68(2):288-95. PubMed ID: 17335328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin syndrome from fluvoxamine and buspirone.
    Baetz M; Malcolm D
    Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727
    [No Abstract]   [Full Text] [Related]  

  • 27. A placebo-controlled clinical trial of L-tryptophan in premenstrual dysphoria.
    Steinberg S; Annable L; Young SN; Liyanage N
    Biol Psychiatry; 1999 Feb; 45(3):313-20. PubMed ID: 10023508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone.
    Cassidy EM; Tomkins E; Sharifi N; Dinan T; Hardiman O; O'Keane V
    Pain; 2003 Feb; 101(3):283-290. PubMed ID: 12583871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study.
    van Vliet IM; den Boer JA; Westenberg HG; Pian KL
    J Clin Psychiatry; 1997 Apr; 58(4):164-8. PubMed ID: 9164427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible serotonin syndrome associated with buspirone added to fluoxetine.
    Manos GH
    Ann Pharmacother; 2000; 34(7-8):871-4. PubMed ID: 10928399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probable nefazodone-induced mania in a patient with unreported bipolar disorder.
    Zaphiris HA; Blaisdell GD; Jermain DM
    Ann Clin Psychiatry; 1996 Dec; 8(4):207-10. PubMed ID: 8986316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nefazodone: aspects of efficacy.
    Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
    J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled comparison of nefazodone and amitriptyline in major depressive inpatients.
    Ansseau M; Darimont P; Lecoq A; De Nayer A; Evrard JL; Krémer P; Devoitille JM; Dierick M; Mertens C; Mesotten F
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):254-60. PubMed ID: 7862904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention.
    Michelson D; Bancroft J; Targum S; Kim Y; Tepner R
    Am J Psychiatry; 2000 Feb; 157(2):239-43. PubMed ID: 10671393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial.
    Schmidt PJ; Grover GN; Rubinow DR
    Arch Gen Psychiatry; 1993 Jun; 50(6):467-73. PubMed ID: 8498881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buspirone, a serotonergic 5-HT1A agonist, is active in cerebellar ataxia. A new fact in favor of the serotonergic theory of ataxia.
    Trouillas P; Xie J; Adeleine P
    Prog Brain Res; 1997; 114():589-99. PubMed ID: 9193169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.
    Wynchank D; Berk M
    Hum Psychopharmacol; 2003 Jun; 18(4):271-5. PubMed ID: 12766931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buspirone and lorazepam in the treatment of generalized anxiety disorder in outpatients.
    Laakmann G; Schüle C; Lorkowski G; Baghai T; Kuhn K; Ehrentraut S
    Psychopharmacology (Berl); 1998 Apr; 136(4):357-66. PubMed ID: 9600581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.
    Thys-Jacobs S; Starkey P; Bernstein D; Tian J
    Am J Obstet Gynecol; 1998 Aug; 179(2):444-52. PubMed ID: 9731851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria.
    Eriksson E
    Int Clin Psychopharmacol; 1999 May; 14 Suppl 2():S27-33. PubMed ID: 10471170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.